Quantifying the blood oxygenation level dependent effect in cerebral blood volume-weighted functional MRI at 9.4T

Magnetic Resonance in Medicine

Volumn 58, Issue 3, 2007, Pages 616-621

  Lu, Hanbing ^a   Scholl, Clara A ^a   Zuo, Yantao ^a   Stein, Elliot A ^a   Yang, Yihong ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

BOLD; BOLD contamination; CBV; fMRI; Superparamagnetic contrast agent

Indexed keywords

BLOOD; HEMODYNAMICS; OXYGENATION; SIGNAL SYSTEMS; SPIN POLARIZATION; SUPERPARAMAGNETISM;

BLOOD OXYGENATION LEVEL DEPENDENT; BOLD; CEREBRAL BLOOD VOLUME; CEREBRAL BLOOD VOLUME(CBV); CONTRAST AGENT; FMRI; FUNCTIONAL MRI (FMRI); GRADIENT ECHO SEQUENCES;

FUNCTIONAL NEUROIMAGING;

CONTRAST MEDIUM; IRON;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; BLOOD OXYGENATION; BRAIN BLOOD FLOW; FUNCTIONAL MAGNETIC RESONANCE IMAGING; MATHEMATICAL MODEL; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING;

EID: 36349028147     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21354     Document Type: Article

References (20)

1. Mandeville J, Moore J, Chesler D, Carrido L, Weissleder R, Weisskoff R. Dynamic liver imaging with iron oxide agents: effects of size and biodistribution on contrast. Magn Reson Med 1997;37:885-890.
2. Mandeville JB, Jenkins BG, Chen YC, Choi JK, Kim YR, Belen D, Liu C, Kosofsky BE, Marota JJ. Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T. Magn Reson Med 2004;52:1272-1281.
3. Vanzetta I, Slovin H, Omer DB, Grinvald A. Columnar resolution of blood volume and oximetry functional maps in the behaving monkey; implications for FMRI. Neuron 2004;42:843-854.
4. Sheth SA, Nemoto M, Guiou M, Walker M, Pouratian N, Hageman N, Toga AW. Columnar specificity of microvascular oxygenation and volume responses: implications for functional brain mapping. J Neurosci 2004;24:634-641.
5. Lu H, Patel S, Luo F, Li SJ, Hillard CJ, Ward BD, Hyde JS. Spatial correlations of laminar BOLD and CBV responses to rat whisker stimulation with neuronal activity localized by Fos expression. Magn Reson Med 2004;52:1060-1068.
6. Harel N, Lin J, Moeller S, Ugurbil K, Yacoub E. Combined imaging-histological study of cortical laminar specificity of fMRI signals. Neuroimage 2006;29:879-887.
7. Zhao F, Wang P, Hendrich K, Ugurbil K, Kim SG. Cortical layer-dependent BOLD and CBV responses measured by spin-echo and gradient-echo fMRI: insights into hemodynamic regulation. Neuroimage 2006;30:1149-1160.
8. Ogawa S, Menon RS, Tank DW, Kim S-G, Merkle H, Ellermann JM, Ugurbil K. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. Biophys J 1993;64:800-812.
9. Boxerman JL, Bandettini PA, Kwong KK, Baker JR, Davis TJ, Rosen BR, Weisskoff RM. The intravascular contribution to fMRI signal changes: Monte Carlo modeling and diffusion-weighted studies in vivo. Magn Reson Med 1995;34:4-10.
10. Lee SP, Silva AC, Kim SG. Comparison of diffusion-weighted high-resolution CBF and spin-echo BOLD fMRI at 9.4 T. Magn Reson Med 2002;47:736-741.
11. Gati JS, Menon RS, Ugurbil K, Rutt BK. Experimental determination of the BOLD field strength dependence in vessels and tissue. Magn Reson Med 1997;38:296-302.
12. 2* and functional contrast to noise ratio. In: Proceedings of the 2nd Annual Meeting of ISMRM, San Francisco, CA, USA, 1994;434.
13. Lu H, Gitajn L, Rea W, Yang Y and Stein EA. Quantifying the BOLD Contribution in CBV-Weighted fMRI at 9.4T. In: Proceedings of the 14th Annual Meeting of ISMRM, Seattle, USA, 2006. p 2117.
14. Tropres I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L, Decorps M. Vessel size imaging. Magn Reson Med 2001;45:397-408.
15. Kiselev VG, Strecker R, Ziyeh S, Speck O, Hennig J. Vessel size imaging in humans. Magn Reson Med 2005;53:553-563.
16. Paxino G and Watson C. The rat brain in stereotaxic coordinates. Academic Press, San Diego, 1998.
17. Sharma R, Saini S, Ros PR, Hahn PF, Small WC, de Lange EE, Stillman AE, Edelman RR, Runge VM, Outwater EK, Morris M, Lucas M. Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial data. J Magn Reson Imaging 1999;9:291-294.
18. Leite FP, Tsao D, Vanduffel W, Fize D, Sasaki Y, Wald LL, Dale AM, Kwong KK, Orban GA, Rosen BR, Tootell RB, Mandeville JB. Repeated fMRI using iron oxide contrast agent in awake, behaving macaques at 3 Tesla. Neuroimage 2002;16:283-294.
19. Wise RA. Neurobiology of addiction. Curr Opin Neurobiol 1996;6:243-251.
20. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Magnetic Resonance Imaging: Physical Principles and Sequence Design. New York: John Wiley & Sons; 1999. p 741-755.